Kenneth J Warrington Selected Research

Rheumatoid Vasculitis

1/2020	Rituximab Therapy for Systemic Rheumatoid Vasculitis: Indications, Outcomes, and Adverse Events.
1/2015	Rheumatoid vasculitis: an update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth J Warrington Research Topics

Disease

17	Giant Cell Arteritis (Horton Disease) 01/2022 - 08/2010
16	Vasculitis (Vasculitides) 06/2022 - 07/2009
9	Takayasu Arteritis (Arteritis, Takayasu's) 01/2022 - 02/2011
7	Inflammation (Inflammations) 01/2022 - 01/2009
6	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 05/2022 - 07/2009
6	Rheumatoid Arthritis 01/2022 - 06/2004
5	VEXAS syndrome 03/2022 - 10/2021
3	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2022 - 08/2010
2	Churg-Strauss Syndrome (Allergic Angiitis) 05/2022 - 01/2021
2	Aneurysm (Aneurysms) 01/2022 - 10/2009
2	Infections 01/2022 - 12/2014
2	Microscopic Polyangiitis 01/2022 - 07/2009
2	Aortitis 01/2022 - 01/2018
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2022 - 07/2009
2	Neoplasms (Cancer) 01/2021 - 02/2011
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2011
2	Rheumatoid Vasculitis 01/2020 - 01/2015
2	Hypertension (High Blood Pressure) 11/2017 - 02/2016
2	Abdominal Aortic Aneurysm 01/2014 - 01/2011
2	Polyarteritis Nodosa (Periarteritis Nodosa) 10/2012 - 02/2011
2	Necrosis 08/2010 - 01/2006
2	Hyperaldosteronism (Conn Syndrome) 11/2003 - 08/2003
2	Heart Failure 09/2003 - 08/2003
1	Rare Diseases (Rare Disease) 05/2022
1	Hemorrhage 01/2022
1	Hypothyroidism 01/2022
1	Diplopia (Double Vision) 01/2022
1	Nausea 01/2022
1	Fatigue 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	COVID-19 01/2022
1	Ischemia 01/2022
1	Multiple Myeloma 10/2021
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Arthritis (Polyarthritis) 01/2021
1	Lung Injury 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Pericarditis 01/2021
1	Pleurisy (Pleuritis) 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2020
1	Kidney Diseases (Kidney Disease) 11/2020
1	Disease Progression 01/2020

Drug/Important Bio-Agent (IBA)

9	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2022 - 07/2009
8	GlucocorticoidsIBA 01/2021 - 08/2010
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2003
4	Rituximab (Mabthera)FDA Link 01/2021 - 01/2020
4	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2016 - 10/2009
3	EnzymesIBA 03/2022 - 10/2021
3	Pharmaceutical PreparationsIBA 01/2022 - 08/2003
3	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2019
3	tocilizumab (atlizumab)FDA Link 03/2021 - 12/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 06/2004
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2011 - 02/2002
2	Prednisone (Sone)FDA LinkGeneric 01/2022 - 01/2011
2	AntigensIBA 01/2022 - 01/2006
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2021
2	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2017
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022 - 01/2006
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
2	C-Reactive ProteinIBA 01/2022 - 06/2012
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 11/2020
2	AutoantibodiesIBA 01/2021 - 01/2011
2	CholesterolIBA 01/2021 - 11/2020
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2020
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017 - 07/2009
2	CytokinesIBA 01/2017 - 01/2006
2	Abatacept (Orencia)FDA Link 01/2017 - 01/2017
2	AldosteroneIBA 09/2003 - 08/2003
1	HaptoglobinsIBA 01/2022
1	Antirheumatic Agents (DMARD)IBA 01/2022
1	N 30IBA 01/2022
1	baricitinibIBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	NucleotidesIBA 01/2022
1	Codon (Codons)IBA 01/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022
1	Ubiquitin-Activating Enzymes (Ubiquitin-Activating Enzyme)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	ruxolitinibIBA 01/2022
1	mavrilimumabIBA 01/2022
1	Methionine (L-Methionine)FDA Link 01/2022
1	CEP 33779IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Janus Kinase 3IBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	CryoglobulinsIBA 01/2021
1	SteroidsIBA 01/2021
1	Bendamustine Hydrochloride FDA Link 01/2021
1	HLA-DQ8 antigenIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	SmokeIBA 01/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2020

Therapy/Procedure

17	Therapeutics 06/2022 - 06/2004
2	Biological Therapy 05/2016 - 01/2015
2	Duration of Therapy 08/2012 - 08/2010
1	Telescopes 01/2022
1	Plasma Exchange 11/2020
1	Length of Stay 03/2019